Page last updated: 2024-10-22

albuterol and Lung Injury, Ventilator-Induced

albuterol has been researched along with Lung Injury, Ventilator-Induced in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gowan, M1
Bushwitz, J1
Watts, P1
Silver, PC1
Jackson, M1
Hampton, N1
Kollef, MH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Common Canister Protocol for Metered Dose Inhaler Administration in Mechanically Ventilated Patients[NCT01935388]Phase 4354 participants (Actual)Interventional2013-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for albuterol and Lung Injury, Ventilator-Induced

ArticleYear
Use of a Shared Canister Protocol for the Delivery of Metered-Dose Inhalers in Mechanically Ventilated Subjects.
    Respiratory care, 2016, Volume: 61, Issue:10

    Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Combined Modality Therapy; Femal

2016